Skip to main content
Advertisement
Advertisement

BNTX

BNTX logo

BioNTech SE - ADR

98.13
USD
Sponsored
-0.53
-0.54%
Sep 09, 15:59 UTC -4
Closed
exchange

After-Market

97.72

-0.41
-0.41%

BNTX Earnings Reports

Positive Surprise Ratio

BNTX beat 18 of 28 last estimates.

64%

Next Report

Date of Next Report
Nov 03, 2026
Estimate for Q3 26 (Revenue/ EPS)
$1.07B
/
$0.81
Implied change from Q2 26 (Revenue/ EPS)
+913.66%
/
-125.00%
Implied change from Q3 25 (Revenue/ EPS)
-29.53%
/
-775.00%

BioNTech SE - ADR earnings per share and revenue

On Aug 04, 2026, BNTX reported earnings of -3.24 USD per share (EPS) for Q2 26, missing the estimate of -2.13 USD, resulting in a -51.91% surprise. Revenue reached 105.60 million, compared to an expected 160.90 million, with a -34.37% difference. The market reacted with a -0.98% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 7 analysts forecast an EPS of 0.81 USD, with revenue projected to reach 1.07 billion USD, implying an decrease of -125.00% EPS, and increase of 913.66% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Clinuvel Pharmaceuticals Limited - ADR
Report Date
Aug 27, 2026 For Q4 26
Estimate
$0.50
Actual
-
Surprise
-
FAQ
For Q2 2026, BioNTech SE - ADR reported EPS of -$3.24, missing estimates by -51.91%, and revenue of $105.60M, -34.37% below expectations.
The stock price moved down -0.98%, changed from $92.25 before the earnings release to $91.35 the day after.
The next earning report is scheduled for Nov 03, 2026.
Based on 7 analysts, BioNTech SE - ADR is expected to report EPS of $0.81 and revenue of $1.07B for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement